Xingbao Li1, Lian Du2, Gregory L Sahlem3, Bashar W Badran3, Scott Henderson3, Mark S George4. 1. Brain Stimulation Division, Department of Psychiatry, Medical University of South Carolina, Charleston, SC, 29425, USA; Center for Biomedical Imaging, Medical University of South Carolina, Charleston, SC, 29425, USA. Electronic address: lixi@musc.edu. 2. Brain Stimulation Division, Department of Psychiatry, Medical University of South Carolina, Charleston, SC, 29425, USA; Department of Psychiatry, Chongqing Medical University, Chongqing, China. 3. Brain Stimulation Division, Department of Psychiatry, Medical University of South Carolina, Charleston, SC, 29425, USA. 4. Brain Stimulation Division, Department of Psychiatry, Medical University of South Carolina, Charleston, SC, 29425, USA; Center for Biomedical Imaging, Medical University of South Carolina, Charleston, SC, 29425, USA; Ralph H. Johnson VA Medical Center, Charleston, SC, 29425, USA.
Abstract
BACKGROUND: Previous studies reported that repetitive transcranial magnetic stimulation (rTMS) can reduce cue-elicited craving and decrease cigarette consumption in smokers. The mechanism of this effect however, remains unclear. We used resting-state functional magnetic resonance imaging (rsfMRI) to test the effect of rTMS in non-treatment seeking smokers. METHODS: We used a single blinded, sham-controlled, randomized counterbalanced crossover design where participants underwent two visits separated by at least 1 week. Participants received active rTMS over the left dorsolateral prefrontal cortex (DLPFC) during one of their visits, and sham rTMS during their other visit. They had two rsFMRI scans before and after each rTMS session. We used the same rTMS stimulation parameters as in a previous study (10Hz, 5s-on, 10s-off, 100% resting motor threshold, 3000 pulses). RESULTS:Ten non-treatment-seeking, nicotine-dependent, cigarette smokers (6 women, an average age of 39.72 and an average cigarette per day of 17.30) finished the study. rsFMRI results demonstrate that as compared to a single session of sham rTMS, a single session of active rTMS inhibits brain activity in the right insula and thalamus in fractional amplitude of low frequency fluctuation (fALFF). For intrinsic brain connectivity comparisons, active TMS resulted in significantly decreased connectivity from the site of rTMS to the left orbitomedial prefrontal cortex. CONCLUSIONS: This data suggests that one session of rTMS can reduce activity in the right insula and right thalamus as measured by fALFF. The data also demonstrates that rTMS can reduce rsFC between the left DLPFC and the medial orbitofrontal cortex.
RCT Entities:
BACKGROUND: Previous studies reported that repetitive transcranial magnetic stimulation (rTMS) can reduce cue-elicited craving and decrease cigarette consumption in smokers. The mechanism of this effect however, remains unclear. We used resting-state functional magnetic resonance imaging (rsfMRI) to test the effect of rTMS in non-treatment seeking smokers. METHODS: We used a single blinded, sham-controlled, randomized counterbalanced crossover design where participants underwent two visits separated by at least 1 week. Participants received active rTMS over the left dorsolateral prefrontal cortex (DLPFC) during one of their visits, and sham rTMS during their other visit. They had two rsFMRI scans before and after each rTMS session. We used the same rTMS stimulation parameters as in a previous study (10Hz, 5s-on, 10s-off, 100% resting motor threshold, 3000 pulses). RESULTS: Ten non-treatment-seeking, nicotine-dependent, cigarette smokers (6 women, an average age of 39.72 and an average cigarette per day of 17.30) finished the study. rsFMRI results demonstrate that as compared to a single session of sham rTMS, a single session of active rTMS inhibits brain activity in the right insula and thalamus in fractional amplitude of low frequency fluctuation (fALFF). For intrinsic brain connectivity comparisons, active TMS resulted in significantly decreased connectivity from the site of rTMS to the left orbitomedial prefrontal cortex. CONCLUSIONS: This data suggests that one session of rTMS can reduce activity in the right insula and right thalamus as measured by fALFF. The data also demonstrates that rTMS can reduce rsFC between the left DLPFC and the medial orbitofrontal cortex.
Authors: James Loughead; E Paul Wileyto; Kosha Ruparel; Mary Falcone; Ryan Hopson; Ruben Gur; Caryn Lerman Journal: Neuropsychopharmacology Date: 2014-12-03 Impact factor: 7.853
Authors: Xingbao Li; Karen J Hartwell; Jeffery Borckardt; James J Prisciandaro; Michael E Saladin; Paul S Morgan; Kevin A Johnson; Todd Lematty; Kathleen T Brady; Mark S George Journal: Addict Biol Date: 2012-03-28 Impact factor: 4.280
Authors: Xingbao Li; Raffaella Ricci; Charles H Large; Berry Anderson; Ziad Nahas; Daryl E Bohning; Mark S George Journal: Psychopharmacology (Berl) Date: 2010-03-02 Impact factor: 4.530
Authors: Kathryn I Pollak; Cheryl A Oncken; Isaac M Lipkus; Pauline Lyna; Geeta K Swamy; Pamela K Pletsch; Bercedis L Peterson; R Phillips Heine; Rebecca J Namenek Brouwer; Laura Fish; Evan R Myers Journal: Am J Prev Med Date: 2007-10 Impact factor: 5.043
Authors: Morgana Croce da Silva; Catarine Lima Conti; Jaisa Klauss; Luana Gaburro Alves; Henrique Mineiro do Nascimento Cavalcante; Felipe Fregni; Michael A Nitsche; Ester Miyuki Nakamura-Palacios Journal: J Physiol Paris Date: 2013-07-25
Authors: Merideth A Addicott; Bruce Luber; Duy Nguyen; Hannah Palmer; Sarah H Lisanby; Lawrence Gregory Appelbaum Journal: Brain Connect Date: 2019-04-02
Authors: Mary Falcone; Leah Bernardo; E Paul Wileyto; Cheyenne Allenby; Anne Marie Burke; Roy Hamilton; Mario Cristancho; Rebecca L Ashare; James Loughead; Caryn Lerman Journal: Drug Alcohol Depend Date: 2018-11-13 Impact factor: 4.492
Authors: Hamed Ekhtiari; Hosna Tavakoli; Giovanni Addolorato; Chris Baeken; Antonello Bonci; Salvatore Campanella; Luis Castelo-Branco; Gaëlle Challet-Bouju; Vincent P Clark; Eric Claus; Pinhas N Dannon; Alessandra Del Felice; Tess den Uyl; Marco Diana; Massimo di Giannantonio; John R Fedota; Paul Fitzgerald; Luigi Gallimberti; Marie Grall-Bronnec; Sarah C Herremans; Martin J Herrmann; Asif Jamil; Eman Khedr; Christos Kouimtsidis; Karolina Kozak; Evgeny Krupitsky; Claus Lamm; William V Lechner; Graziella Madeo; Nastaran Malmir; Giovanni Martinotti; William M McDonald; Chiara Montemitro; Ester M Nakamura-Palacios; Mohammad Nasehi; Xavier Noël; Masoud Nosratabadi; Martin Paulus; Mauro Pettorruso; Basant Pradhan; Samir K Praharaj; Haley Rafferty; Gregory Sahlem; Betty Jo Salmeron; Anne Sauvaget; Renée S Schluter; Carmen Sergiou; Alireza Shahbabaie; Christine Sheffer; Primavera A Spagnolo; Vaughn R Steele; Ti-Fei Yuan; Josanne D M van Dongen; Vincent Van Waes; Ganesan Venkatasubramanian; Antonio Verdejo-García; Ilse Verveer; Justine W Welsh; Michael J Wesley; Katie Witkiewitz; Fatemeh Yavari; Mohammad-Reza Zarrindast; Laurie Zawertailo; Xiaochu Zhang; Yoon-Hee Cha; Tony P George; Flavio Frohlich; Anna E Goudriaan; Shirley Fecteau; Stacey B Daughters; Elliot A Stein; Felipe Fregni; Michael A Nitsche; Abraham Zangen; Marom Bikson; Colleen A Hanlon Journal: Neurosci Biobehav Rev Date: 2019-07-02 Impact factor: 8.989
Authors: Yafen Chen; Yoon-Hee Cha; Diamond Gleghorn; Benjamin C Doudican; Guofa Shou; Lei Ding; Han Yuan Journal: J Neural Eng Date: 2021-11-30 Impact factor: 5.379
Authors: Xingbao Li; Karen J Hartwell; Scott Henderson; Bashar W Badran; Kathleen T Brady; Mark S George Journal: Brain Stimul Date: 2020-06-10 Impact factor: 8.955
Authors: Dara G Ghahremani; Jean-Baptiste Pochon; Maylen Perez Diaz; Rachel F Tyndale; Andy C Dean; Edythe D London Journal: Neuropsychopharmacology Date: 2021-05-25 Impact factor: 7.853
Authors: Claire E Wilcox; Christopher C Abbott; Vince D Calhoun Journal: Prog Neuropsychopharmacol Biol Psychiatry Date: 2018-06-25 Impact factor: 5.067